Agenus, Inc. (AGEN)
3.24
+0.17
(+5.54%)
USD |
NASDAQ |
Feb 24, 12:44
Agenus EPS Diluted (Quarterly) : 1.944 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cardiff Oncology, Inc. | -0.1684 |
| Curis, Inc. | -0.4929 |
| LadRx Corp. | -1.453 |
| Plus Therapeutics, Inc. | -0.0412 |
| Windtree Therapeutics, Inc. | -1.085 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 63.91M |
| Revenue (Quarterly) | 30.24M |
| Total Expenses (Quarterly) | -33.68M |
| Enterprise Value | 441.71M |
| Gross Profit Margin (Quarterly) | 87.85% |
| Earnings Yield | -65.66% |
| Normalized Earnings Yield | -132.85 |